Thomas A. Fleisher

10.7k total citations · 2 hit papers
55 papers, 5.5k citations indexed

About

Thomas A. Fleisher is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Thomas A. Fleisher has authored 55 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 14 papers in Molecular Biology and 12 papers in Epidemiology. Recurrent topics in Thomas A. Fleisher's work include Immune Cell Function and Interaction (13 papers), Immunotherapy and Immune Responses (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Thomas A. Fleisher is often cited by papers focused on Immune Cell Function and Interaction (13 papers), Immunotherapy and Immune Responses (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Thomas A. Fleisher collaborates with scholars based in United States, Italy and United Kingdom. Thomas A. Fleisher's co-authors include Irwin M. Feuerstein, Leonard H. Wexler, Crystal L. Mackall, Ronald E. Gress, Thomas A. Selvaggi, Robert Walker, Mary P. Andrich, Seth M. Steinberg, Marc E. Horowitz and Clara C. Chen and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Thomas A. Fleisher

55 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T Lymphocyte-Directed Gene Therapy for ADA ⁻ SCID: Initial Trial Results After 4 Years

1995 983 citations R. Michael Blaese, Kenneth W. Culver et al. profile →
Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy

1995 866 citations Thomas A. Fleisher, Irwin M. Feuerstein et al. profile →

Peers

Countries citing papers authored by Thomas A. Fleisher

Since Specialization

Citations

This map shows the geographic impact of Thomas A. Fleisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Fleisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Fleisher more than expected).

Fields of papers citing papers by Thomas A. Fleisher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Fleisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Fleisher. The network helps show where Thomas A. Fleisher may publish in the future.

Co-authorship network of co-authors of Thomas A. Fleisher

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Fleisher. A scholar is included among the top collaborators of Thomas A. Fleisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Fleisher. Thomas A. Fleisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cushing syndrome and glucocorticoids: T-cell lymphopenia, apoptosis, and rescue by IL-21 2021 ·Journal of Allergy and Clinical Immunology ·SuJin Hwang, Christina Tatsi, Hye Sun Kuehn, Julie E. Niemela, Jennifer Stoddard, Yan Su, Maya Lodish, Gülbû Uzel, Rosanne Spolski, Warren J. Leonard, Steven M. Holland, Thomas A. Fleisher, Constantine A. Stratakis, Sergio D. Rosenzweig	5
2	The importance of allergic disease in public health: an iCAALL statement 2018 ·World Allergy Organization Journal ·Mario Sánchez‐Borges, Bryan Martin, Antonella Muraro, Robert A. Wood, Ioana Agache, Ignacio J. Ansotegui, Thomas B. Casale, Thomas A. Fleisher, Peter W. Hellings, Nikolaos G. Papadopoulos, David B. Peden, James L. Sublett, Stephen A. Tilles, Lanny J. Rosenwasser	65
3	The microbiome in allergic disease: Current understanding and future opportunities—2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology 2017 ·Journal of Allergy and Clinical Immunology ·Yvonne J. Huang, Benjamin J. Marsland, Supinda Bunyavanich, Liam O’Mahony, Donald Y.M. Leung, Antonella Muraro, Thomas A. Fleisher	239
4	B-cell activating factor (BAFF) is elevated in Chronic Granulomatous Disease 2013 ·Clinical Immunology ·Kabir Matharu, Kol A. Zarember, Beatriz E. Marciano, Douglas B. Kuhns, Christine Spalding, Mary Garofalo, Thomas DiMaggio, Tyra Estwick, Chiung‐Yu Huang, Danielle Fink, Debra Long Priel, Thomas A. Fleisher, Steven M. Holland, Harry L. Malech, John I. Gallin	7
5	Elevated vitamin B12 levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes 2012 ·Clinical Biochemistry ·Raffick A.R. Bowen, Kennichi Dowdell, Janet K. Dale, Steven K. Drake, Thomas A. Fleisher, Glen L. Hortin, Alan T. Remaley, Ebba Nexø, V. Koneti Rao	25
6	The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome 2011 ·Blood ·David H. McDermott, Qian Liu, Jean Ulrick, Nana Kwatemaa, Sandra Anaya‐O’Brien, Scott Penzak, (unknown), Debra A. Long Priel, Corin Kelly, Mary Garofalo, Patricia Littel, Martha Marquesen, (unknown), Rosamma DeCastro, Thomas A. Fleisher, Douglas B. Kuhns, Harry L. Malech, Philip M. Murphy	95
7	Allergy Testing in Childhood: Using Allergen-Specific IgE Tests 2011 ·PEDIATRICS ·Scott H. Sicherer, Robert A. Wood, (unknown), Stuart L. Abramson, (unknown), Thomas A. Fleisher, Mitchell R. Lester, Todd A. Mahr, Elizabeth C. Matsui, Frank S. Virant, Paul V. Williams	95
8	Autoimmune lymphoproliferative syndrome 2004 ·Current Opinion in Allergy and Clinical Immunology ·João Bosco Oliveira, Thomas A. Fleisher	35
9	Diagnostic Flow Cytometry in Hematologic Malignancies 2003 ·Humana Press eBooks ·Gerald E. Marti, Maryalice Stetler‐Stevenson, Thomas A. Fleisher	2
10	Severe phenotype of chronic granulomatous disease presenting in a female with a de novo mutation in gp91-phox and a non familial, extremely skewed X chromosome inactivation 2003 ·Clinical Immunology ·(unknown), Steven M. Holland, (unknown), Thomas A. Fleisher, Li Ding, Sebastian Brenner, Harry L. Malech, Joachim Roesler	52
11	Autoimmune Lymphoproliferative Syndrome with Defective Fas: Genotype Influences Penetrance 1999 ·The American Journal of Human Genetics ·Christine E. Jackson, Roxanne Fischer, Amy P. Hsu, Stacie M. Anderson, Youngnim Choi, Jin Wang, Janet K. Dale, Thomas A. Fleisher, Lindsay Middelton, Michael C. Sneller, Michael J. Lenardo, Stephen E. Straus, Jennifer M. Puck	169
12	Detection of Intracellular Phosphorylated STAT-1 by Flow Cytometry 1999 ·Clinical Immunology ·Thomas A. Fleisher, Susan E. Dorman, Jill Anderson, M Vail, Margaret R. Brown, Steven M. Holland	94
13	Intestinal lymphangiectasia, a disease characterized by selective loss of naive CD45RA+ lymphocytes into the gastrointestinal tract 1998 ·European Journal of Immunology ·Ivan J. Fuss, Warren Strober, Brenda A. Cuccherini, (unknown), Xavier Bossuyt, (unknown), Thomas A. Fleisher, Kevin Horgan	48
14	The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis 1998 ·The Journal of Pediatrics ·Anthony J. Infante, Howard A. Britton, Thomas S. DeNapoli, Lindsay Middelton, Michael J. Lenardo, Christine E. Jackson, Jin Wang, Thomas A. Fleisher, Stephen E. Straus, Jennifer M. Puck	91
15	Comparative analysis of whole blood lysis methods for flow cytometry 1997 ·Cytometry ·Xavier Bossuyt, Gerald E. Marti, Thomas A. Fleisher	10
16	Safety and efficacy of strength training in patients with sporadic inclusion body myositis 1997 ·Muscle & Nerve ·Sidney A. Spector, J. T. Lemmer, Boyd M. Koffman, Thomas A. Fleisher, Irwin M. Feuerstein, Ben F. Hurley, Marinos C. Dalakas	116
17	Frequent occurrence of asplenism and cholelithiasis in patients with autoimmune polyglandular disease type I 1991 ·The American Journal of Medicine ·Theodore C. Friedman, Pamela M. Thomas, Thomas A. Fleisher, Penelope Feuillan, (unknown), Fernando Cassorla, George P. Chrousos	40
18	Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer. 1991 ·PubMed ·Kenneth W. Culver, William Osborne, A. Dusty Miller, Thomas A. Fleisher, M Berger, W.F. Anderson, R. Michael Blaese	50
19	Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide 1990 ·The American Journal of Medicine ·Gary S. Hoffman, Randi Y. Leavitt, Thomas A. Fleisher, (unknown), Anthony S. Fauci	147
20	The interference of T cell activation by calcium channel blocking agents. 1984 ·The Journal of Immunology ·D L Birx, M. Berger, Thomas A. Fleisher	141

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact